Los Angeles Capital Management & Equity Research Inc. Buys 4,960 Shares of Zimmer Biomet Holdings, Inc. (ZBH)

Los Angeles Capital Management & Equity Research Inc. increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 99.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,942 shares of the medical equipment provider’s stock after acquiring an additional 4,960 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in Zimmer Biomet Holdings were worth $1,277,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ZBH. Bronfman E.L. Rothschild L.P. increased its holdings in Zimmer Biomet Holdings by 25.3% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock valued at $106,000 after purchasing an additional 167 shares during the period. Parkside Financial Bank & Trust increased its holdings in Zimmer Biomet Holdings by 2.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after purchasing an additional 22 shares during the period. Parallel Advisors LLC increased its holdings in Zimmer Biomet Holdings by 20.8% during the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $138,000 after purchasing an additional 199 shares during the period. IHT Wealth Management LLC increased its holdings in Zimmer Biomet Holdings by 28.4% during the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock valued at $139,000 after purchasing an additional 256 shares during the period. Finally, Sandy Spring Bank increased its holdings in Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 20 shares during the period. 85.35% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Los Angeles Capital Management & Equity Research Inc. Buys 4,960 Shares of Zimmer Biomet Holdings, Inc. (ZBH)” was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.chaffeybreeze.com/2017/09/19/los-angeles-capital-management-equity-research-inc-buys-4960-shares-of-zimmer-biomet-holdings-inc-zbh.html.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 116.30 on Tuesday. The stock has a market cap of $23.52 billion, a P/E ratio of 33.12 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49. The company has a 50 day moving average price of $114.66 and a 200 day moving average price of $120.77.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 earnings per share. On average, equities analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.83%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

In related news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.07% of the company’s stock.

A number of research analysts recently issued reports on the company. Stifel Nicolaus restated a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Gabelli assumed coverage on Zimmer Biomet Holdings in a report on Thursday, August 24th. They set a “buy” rating and a $142.00 price target on the stock. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. BMO Capital Markets restated a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Finally, Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $136.75.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply